A Randomized, Double-blind, Cross-over Trial in Patients With Irritable Bowel Syndrome Investigating the Efficacy and Safety of PPC-5650 on Sensation and Pain During Standardized Stimulation of the Rectosigmoid.

Trial Profile

A Randomized, Double-blind, Cross-over Trial in Patients With Irritable Bowel Syndrome Investigating the Efficacy and Safety of PPC-5650 on Sensation and Pain During Standardized Stimulation of the Rectosigmoid.

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Jul 2014

At a glance

  • Drugs PPC 5650 (Primary)
  • Indications Irritable bowel syndrome; Pain
  • Focus Therapeutic Use
  • Sponsors Aros Pharma
  • Most Recent Events

    • 20 May 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 19 Jan 2012 Planned end date changed from 1 Mar 2012 to 1 Oct 2012 as reported by ClinicalTrials.gov.
    • 19 Jan 2012 Actual initiation date (Jan 2012) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top